Tag: Eli Lilly and Co

Logistics giants are racing to keep up with healthcare boom as GLP-1s highlight need for cold storage

Eli Lilly says it will file for approval of next-generation obesity drug in 2027 as it clears two more trials

Trump plans generic drug tariffs from 2028 with two-year delay testing U.S. onshoring push

Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising

The market for psychedelic drugs to treat mental health conditions gets a big buy signal

Fat cat? Weight-loss drugs may be coming for your overweight pet

Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction

Healthy Returns: Employers aren’t expanding coverage of GLP-1 obesity drugs – many are finding ways around it

Dow hovers at 53,000 as chip stock weakness holds back market: Live updates

Healthy Returns: Walmart, CVS step in to help seniors navigate Medicare coverage of obesity drugs